Vitality Watch

⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.

Mentioned 1× · first seen 09-sep-2026 · last seen 09-sep-2026

ASAP3–Actin–Autophagy Hepatic Senescence Axis

Current understanding

ASAP3, an ArfGAP-family regulator of actin cytoskeleton dynamics, is nominated as a driver of hepatic aging: mouse Asap3 knockouts show alleviated hepatocyte senescence, restored actin dynamics, enhanced autophagy, and improved mitochondrial function, alongside extended lifespan and healthspan [animal-model]. The proposed mechanism couples cytoskeletal disorganization to autophagic flux and mitochondrial quality control in the liver, but all evidence is preclinical (mouse KO + cell work) with no human translation.

Evidence log

Open questions

Related

Contributing findings

pubmed preclinical
ASAP3 deficiency alleviates hepatic senescence and correlates with extended healthspan in mice.
10-jul-2026 novelty 3 per-area 3 introduces

build build 880 · 2bcef25 · 2026-11-18